Compagnie Lombard Odier SCmA Sells 24,864 Shares of MetLife, Inc. (NYSE:MET)

by · The Cerbat Gem

Compagnie Lombard Odier SCmA decreased its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 7.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 324,581 shares of the financial services provider’s stock after selling 24,864 shares during the quarter. Compagnie Lombard Odier SCmA’s holdings in MetLife were worth $26,771,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of MET. GoalVest Advisory LLC increased its stake in MetLife by 73.3% during the 1st quarter. GoalVest Advisory LLC now owns 390 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 165 shares in the last quarter. Pineridge Advisors LLC acquired a new position in MetLife during the 4th quarter valued at approximately $39,000. Bank & Trust Co acquired a new position in MetLife during the 2nd quarter valued at approximately $39,000. Crewe Advisors LLC increased its stake in MetLife by 602.5% during the 2nd quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 482 shares in the last quarter. Finally, Larson Financial Group LLC increased its stake in MetLife by 72.6% during the 2nd quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 239 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.

MetLife Stock Performance

NYSE MET traded up $1.48 during mid-day trading on Friday, reaching $85.51. 2,587,129 shares of the stock were exchanged, compared to its average volume of 3,349,129. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.16 and a current ratio of 0.16. The company has a market capitalization of $59.89 billion, a P/E ratio of 23.05, a P/E/G ratio of 0.69 and a beta of 1.04. MetLife, Inc. has a 1 year low of $57.91 and a 1 year high of $85.97. The business’s 50 day moving average is $76.87 and its 200-day moving average is $73.71.

MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.13 by $0.15. The business had revenue of $17.82 billion for the quarter, compared to the consensus estimate of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. The company’s revenue was up 7.2% compared to the same quarter last year. During the same period last year, the firm posted $1.94 earnings per share. On average, equities research analysts forecast that MetLife, Inc. will post 8.61 EPS for the current fiscal year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.55%. The ex-dividend date of this dividend is Tuesday, November 5th. MetLife’s payout ratio is 58.76%.

Analyst Ratings Changes

MET has been the topic of a number of recent analyst reports. Morgan Stanley cut their price target on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. Wells Fargo & Company increased their price objective on shares of MetLife from $86.00 to $92.00 and gave the stock an “overweight” rating in a research note on Thursday. Bank of America cut their price objective on shares of MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Barclays started coverage on shares of MetLife in a research note on Wednesday, September 4th. They issued an “overweight” rating and a $91.00 price objective on the stock. Finally, Piper Sandler increased their price objective on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $88.46.

Read Our Latest Stock Analysis on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles